Pharmacologic Cotreatment in Patients With Schizophrenia

Which psychotropic combinations unlock the door to successful treatment?

View the slides in PDF format.

Related Videos
Related Content

Evenamide for Treatment-Resistant Schizophrenia

March 23rd 2023

Here's to a Psychedelic Revolution

April 9th 2022

The Week in Review: March 13-17

March 18th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Prisoner of the Brain: Recognizing the Serious Implications of Catatonia

March 16th 2023

Research Analyzes Caffeine Intake and Levels in Smokers With Bipolar Disorder and Schizophrenia

March 13th 2023

Evenamide for Treatment-Resistant Schizophrenia

March 23rd 2023

Here's to a Psychedelic Revolution

April 9th 2022

The Week in Review: March 13-17

March 18th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Prisoner of the Brain: Recognizing the Serious Implications of Catatonia

March 16th 2023

Research Analyzes Caffeine Intake and Levels in Smokers With Bipolar Disorder and Schizophrenia

March 13th 2023

Evenamide for Treatment-Resistant Schizophrenia

March 23rd 2023

Here's to a Psychedelic Revolution

April 9th 2022

The Week in Review: March 13-17

March 18th 2023

Treating ‘Morally Objectionable’ Patients

September 27th 2021

Prisoner of the Brain: Recognizing the Serious Implications of Catatonia

March 16th 2023

Research Analyzes Caffeine Intake and Levels in Smokers With Bipolar Disorder and Schizophrenia

March 13th 2023
© 2023 MJH Life Sciences

All rights reserved.